prikaz prve stranice dokumenta Bone health and adherence to vitamin D and calcium therapy in early breast cancer patients on endocrine therapy with aromatase inhibitors.
Pristup korisnicima matične ustanove
Znanstveni rad - Izvorni znanstveni rad
Bone health and adherence to vitamin D and calcium therapy in early breast cancer patients on endocrine therapy with aromatase inhibitors.
Breast, 31 (2017), 1; 16-19. https://doi.org/10.1016/j.breast.2016.10.018
Bošković, Lidija; Gašparić, Maja; Petković, Marija; Gugić, Damir; Belac-Lovasić, Ingrid; Soldić, Željko; Petrić Miše, Branka; Dabelić, Nina; Vazdar, Ljubica; Vrdoljak, Eduard

Citirajte ovaj rad

Bošković, L., Gašparić, M., Petković, M., Gugić, D., Belac Lovasić, I., Soldić, Ž. ... Vrdoljak, E. (2017). Bone health and adherence to vitamin D and calcium therapy in early breast cancer patients on endocrine therapy with aromatase inhibitors.. Breast, 31. (1), 16-19. doi: 10.1016/j.breast.2016.10.018

Bošković, Lidija, et al. "Bone health and adherence to vitamin D and calcium therapy in early breast cancer patients on endocrine therapy with aromatase inhibitors.." Breast, vol. 31, br. 1, 2017, str. 16-19. https://doi.org/10.1016/j.breast.2016.10.018

Bošković, Lidija, Maja Gašparić, Marija Petković, Damir Gugić, Ingrid Belac Lovasić, Željko Soldić, Branka Petrić Miše, Nina Dabelić, Ljubica Vazdar i Eduard Vrdoljak. "Bone health and adherence to vitamin D and calcium therapy in early breast cancer patients on endocrine therapy with aromatase inhibitors.." Breast 31, br. 1 (2017): 16-19. https://doi.org/10.1016/j.breast.2016.10.018

Bošković, L., et al. (2017) 'Bone health and adherence to vitamin D and calcium therapy in early breast cancer patients on endocrine therapy with aromatase inhibitors.', Breast, 31(1), str. 16-19. doi: 10.1016/j.breast.2016.10.018

Bošković L, Gašparić M, Petković M, Gugić D, Belac Lovasić I, Soldić Ž, i sur.. Bone health and adherence to vitamin D and calcium therapy in early breast cancer patients on endocrine therapy with aromatase inhibitors.. Breast [Internet]. 2017. [pristupljeno 16.11.2024.];31(1):16-19. doi: 10.1016/j.breast.2016.10.018

L. Bošković, et al., "Bone health and adherence to vitamin D and calcium therapy in early breast cancer patients on endocrine therapy with aromatase inhibitors.", Breast, vol. 31, br. 1, str. 16-19, 2017. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:731047. [Citirano: 16.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:731047
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Bone health and adherence to vitamin D and calcium therapy in early breast cancer patients on endocrine therapy with aromatase inhibitors.
AutorLidija Bošković
AutorMaja Gašparić
AutorMarija Petković
AutorDamir Gugić
AutorIngrid Belac-Lovasić
AutorŽeljko Soldić
AutorBranka Petrić Miše
AutorNina Dabelić
AutorLjubica Vazdar
AutorEduard Vrdoljak
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za onkologiju i radioterapiju)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Onkologija
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
OBJECTIVES: Randomized trials involving aromatase inhibitors (AIs) in the adjuvant treatment of breast cancer patients have reported increased osteoporosis risk. Bone loss can be reduced with appropriate life style, vitamin D and calcium supplements, and with bisphosphonate therapy. The aim of this analysis was to investigate adherence to vitamin D and calcium in postmenopausal breast cancer patients receiving adjuvant non-steroidal AIs, and oncologists' adherence to the bone health guidelines. MATERIAL AND METHODS: This prospective study included 438 newly diagnosed patients and those who have already been receiving non-steroidal AIs for up to 3.5 years. Median endocrine therapy duration before recruitment in the study was 10.5 months (interquartile 4.8-26.6). RESULTS: Densitometry was performed on 142 patients (32.4%) before initiation of endocrine therapy, and on additional 38 (8.6%) patients at second study visit. Densitometry was not performed on 258 (59%) patients. Vitamin D and calcium were prescribed to 329/438 (75.1%) patients at some point during the study. Patients who took more than 80% of the prescribed dose were considered adherent. Self-reported adherence was 88.4%. Osteoporosis was diagnosed in 24 patients (5.5%) of the total study population, bearing in mind that 258/438 (59%) patients did not have densitometry. Bisphosphonates were prescribed to 54/438 (12.3%) patients, whilst only 19 (35.2%) of those had osteoporosis. CONCLUSION: In this analysis, lack of oncologists' adherence to the bone health guidelines was observed. In addition, a significant proportion of the patients did not adhere to the vitamin D and calcium.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaBreast
Brojčani podacivol. 31, br. 1, str. 16-19
p-ISSN0960-9776
DOIhttps://doi.org/10.1016/j.breast.2016.10.018
URN:NBNurn:nbn:hr:184:731047
Datum objave publikacije2017
URL dokumentahttp://bib.irb.hr/999245
Vrsta resursaTekst
Prava pristupaInstitucijski pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2022-02-08 14:01:43